Contrasting Histopathology and Crystal Deposits in Kidneys of Idiopathic Stone Formers Who Produce Hydroxy Apatite, Brushite, or Calcium Oxalate Stones

Anatomical Record

Volumn 297, Issue 4, 2014, Pages 731-748

  Evan, Andrew P ^a,b   Lingeman, James E ^b   Worcester, Elaine M ^c   Sommer, Andre J ^d   Phillips, Carrie L ^e   Williams, James C ^a   Coe, Fredric L ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b METHODIST HOSPITAL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d MIAMI UNIVERSITY   (United States)

^e INDIANA UNIVERSITY HEALTH   (United States)

Author keywords

CaP stone formers; Surgical anatomy; Ultrastructure

Indexed keywords

CALCIUM PHOSPHATE DIBASIC; HYDROXYAPATITE;

ADULT; AGED; ARTICLE; CALCIUM EXCRETION; CALCIUM OXALATE STONE; CLINICAL ARTICLE; CORTICAL BIOPSY; CRYSTALLIZATION; DIGITAL PHOTOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; INFRARED PHOTOGRAPHY; KIDNEY BIOPSY; MALE; MIDDLE AGED; NEPHROLITHIASIS; PRIORITY JOURNAL; STONE ANALYSIS; URINALYSIS; URINE PH; YOUNG ADULT;

CAP STONE FORMERS; SURGICAL ANATOMY; ULTRASTRUCTURE;

ADOLESCENT; ADULT; AGED; CALCIUM OXALATE; CALCIUM PHOSPHATES; DURAPATITE; FEMALE; HUMANS; KIDNEY CALCULI; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; X-RAY MICROTOMOGRAPHY; YOUNG ADULT;

EID: 84896319246     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.22881     Document Type: Article

References (35)

1. Asplin JR, Parks JH, Chen MS, Lieske JC, Toback FG, Pillay SN, Nakagawa Y, Coe FL. 1999. Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int 56:1505-1516.
2. Asplin JR, Parks JH, Nakagawa Y, Coe FL. 2002. Reduced crystallization inhibition by urine from women with nephrolithiasis. Kidney Int 61:1821-1829.
3. Barbey F, Nseir G, Ferrier C, Burnier M, Daudon M. 2004. Carbonic anhydrase inhibitors and calcium phosphate stones. Nephrologie 25:169-172.
4. Burry AF, Axelsen RA, Trolove P, Saal JR. 1976. Calcification in the renal medulla: a classification based on a prospective study of 2261 necropies. Human Pathol 7:435-449.
5. Coe FL, Evan A, Worcester E. 2005. Kidney stone disease. J Clin Invest 115:2598-2608.
6. Coe FL, Evan AP, Lingeman JE, Worcester EM. 2010. Plaque and deposits in nine human stone diseases. Urol Res 38:239-247.
7. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Patterson RF, Kuo RL, Grynpas M. 2003. Randall Plaque of patients with nephrolithisis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607-616.
8. Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M. 2005. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576-591.
9. Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Philips CL, Worcester EM. 2006a. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227-2235.
10. Evan A, Lingeman J, Coe FL, Worcester E. 2006b. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69:1313-1318.
11. Evan AP, Lingeman J, Coe F, Shao Y, Miller N, Matlaga B, Phillips C, Sommer A, Worcester EM. 2007. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71:795-801.
12. Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM. 2008a. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec 291:325-334.
13. Evan AP, Lingeman JE, Coe FL, Miller N, Bledsoe S, Sommer A, Williams J. Shao Y, Worcester E. 2008b. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int 74:223-229.
14. Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC Jr, Krambeck AE, Worcester EM. 2009. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int 76:1081-1088.
15. Evan AP, Lingeman JE, Worcester EM. Bledsoe SB, Sommer AJ, Williams JC, Jr., Krambeck AE, Phillips CL, Coe FL. 2010a. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int 78:310-317.
16. Evan AP, Weinman EJ, Wu X-R. Lingeman JE, Worcester EM, Coe FL. 2010b. Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null Mice. Urol Res 38:439-452.
17. Fukumoto R, Katayama K, Hayashi T, Matsuoka A, FujomotoN, Koide T, Kashiwagi H, Tagawa T, Onodera T, Ishida M. 2011. Two cases of urolithiiasis induced by topiramate. Hinyokika Kiyo 57:125-128.
18. Gambaro G, Favaro S, D'Angelo A. 2001. Risk for renal failure in nephrolithiasis. Am J Kidney Dis 37:233-243.
19. Gault MH, Chafe LL, Morgan JM, Parfrey PS, Harnett JD, Walsh EA, Prabhakaran VM, Dow D, Colpitts A. 1991. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Medicine 70:345-358.
20. Keddis MT, Rule AD. 2013. Nephrolithiasis and loss of kidney function. Curr Opin Nephrol Hypertens 22:390-396.
21. Kuo RL, Lingeman JE, Evan AP, Parks JH, Bledsoe SB, Patterson RF, Munch LC, Coe FL. 2003. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int 64:2150-2154.
22. Laerum E, Larsen S. 1984. Thiazide prophylaxis of urolithiasis: a double-blind study in general practice. Acta Med Scand 215:383-389.
23. Liu YL, Mo L, Goldfarb D.S, Evan AP, LiangF, Khan SR, Lieske JC, Wu X-R. 2010. Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein. Am J Physiol 299:F469-F478.
24. Miller NL, Gillen DL, Williams JC, JrEvan AP, Bledsoe SB, Coe FL, Worcester EM, Matlaga BR, Munch LC, Lingeman JE. 2009. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int 103:966-971.
25. Pak CYC, Eanes ED, Ruskin B. 1971. Spontaneous preciitation of brushite in urine: evidence that brushite is the rius of renal stones originating as calcium phosphate. Pro Natl Acad Sci USA 68:1456-1460.
26. Pak CYC, Britton F, Peterson R, Ward D, Northcutt C, Breslau NA, McGuire J, Sakhaee K, Bush S, Nicar M, Norman DA, Peters P. 1980. Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria. Am J Med 69:19-30.
27. Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE. 2004. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 66:777-785.
28. Parks JH, Coe FL, Evan AP, Worcester EM. 2009. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant 24:130-136.
29. Peach RJ, Day WA, Ellingsen PJ, McGiven AR. 1988. Ultrastructural localization of Tamm-Horsfall protein in human kidney using immunogold electron microscopy. Histochem J 20:156-164.
30. Qiu SR, Ormer CA. 2008. Dynamics of biomineral formation at the near-molecular level. Chem Rev 108:4784-4822.
31. Tang R, Naacolias GH, Giocondi JL. Hoyer JR, Orme CA. 2006. Dual roles of brushite crystals in calcium oxalate crysallization provide physicochemical mechansims underlying renal stone formation. Kidney Int 70:71-78.
32. Thurgood LA, Ryall RL. 2010. Proteomic analysis of proteins selectively associated with hydroxyapatite, brushite, and uric acid crystals precipitated from human urine. J Proteome Res 9:5402-5412.
33. Vervaet BA, Verhulst A, D'Haese PC, De Broe ME. 2009. Nephrocalcinosis: new insights into mechanisms and consequences. Nephrol Dial Transplant 24:2030-2035.
34. Yasue T. 1969. Histochemical identification of calcium oxalate. Acta Histochem Cytochem 2:83-95.
35. Weiss M, Liapis H, Tomaszewski JE, Arend LJ. 2007. Pyelonephriitis and other infections, reflux nephroloathy, hydronephrosis and nephrolithiasis. In: Jennette JC, Olson JL, Schwarz MM, Silva FG, editors. Heptinstall's pathology of the kidney. Philadelphia, PA: Lippincott Williams and Wilkins. p 991-1031.